The end of dieting: WeightWatchers and Noom are now pushing Ozempic-like miracle drugs over willpower.

The article focuses on the evolution of WeightWatchers, founded by Jean Nidetch, in response to the rise of new weight-loss medications like Ozempic and Wegovy. Nidetch, who transformed her personal struggle with weight into a successful business, established a model based on calorie counting and community support that has persisted for decades. However, the introduction of GLP-1 medications has prompted WeightWatchers and other traditional dieting companies, such as Noom, to adapt their strategies by incorporating telehealth services and prescription options, as they face challenges from these more effective treatments. The shift raises questions about the future of dieting culture and the effectiveness of traditional weight-loss methods, as well as concerns about the potential societal implications of these new medications. [Extracted from the article]